371 related articles for article (PubMed ID: 21198949)
1. Acne-associated syndromes: models for better understanding of acne pathogenesis.
Chen W; Obermayer-Pietsch B; Hong JB; Melnik BC; Yamasaki O; Dessinioti C; Ju Q; Liakou AI; Al-Khuzaei S; Katsambas A; Ring J; Zouboulis CC
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):637-46. PubMed ID: 21198949
[TBL] [Abstract][Full Text] [Related]
2. Acne as a chronic systemic disease.
Zouboulis CC
Clin Dermatol; 2014; 32(3):389-96. PubMed ID: 24767186
[TBL] [Abstract][Full Text] [Related]
3. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
[TBL] [Abstract][Full Text] [Related]
4. Early diagnosis, presenting complaints, and management of hyperandrogenism in adolescents.
Schroeder B
Curr Womens Health Rep; 2001 Oct; 1(2):124-30. PubMed ID: 12112959
[TBL] [Abstract][Full Text] [Related]
5. [Uncommon acne-associated syndromes and their significance in understanding the pathogenesis of acne].
Hong JB; Prucha H; Melnik B; Ziai M; Ring J; Chen W
Hautarzt; 2013 Apr; 64(4):274-9. PubMed ID: 23525534
[TBL] [Abstract][Full Text] [Related]
6. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.
Unluhizarci K; Kaltsas G; Kelestimur F
Eur J Clin Invest; 2012 Jan; 42(1):86-94. PubMed ID: 21623779
[TBL] [Abstract][Full Text] [Related]
7. Acne and systemic disease.
Lolis MS; Bowe WP; Shalita AR
Med Clin North Am; 2009 Nov; 93(6):1161-81. PubMed ID: 19932324
[TBL] [Abstract][Full Text] [Related]
8. SAHA syndrome: female androgenetic alopecia and hirsutism.
Camacho FM
Exp Dermatol; 1999 Aug; 8(4):304-5. PubMed ID: 10439235
[No Abstract] [Full Text] [Related]
9. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
10. The SAHA syndrome.
Orfanos CE; Adler YD; Zouboulis CC
Horm Res; 2000; 54(5-6):251-8. PubMed ID: 11595813
[TBL] [Abstract][Full Text] [Related]
11. Hyperandrogenism and the skin.
Heymann WR
J Am Acad Dermatol; 2004 Jun; 50(6):937-8. PubMed ID: 15153896
[No Abstract] [Full Text] [Related]
12. The clinical evaluation of hirsutism.
Somani N; Harrison S; Bergfeld WF
Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
[TBL] [Abstract][Full Text] [Related]
13. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess.
Rosenfield RL; Lucky AW
Endocrinol Metab Clin North Am; 1993 Sep; 22(3):507-32. PubMed ID: 8243445
[TBL] [Abstract][Full Text] [Related]
14. Difficult and rare forms of acne.
Dessinioti C; Katsambas A
Clin Dermatol; 2017; 35(2):138-146. PubMed ID: 28274350
[TBL] [Abstract][Full Text] [Related]
15. Syndromes of hyperandrogenism in women.
Davis S
Aust Fam Physician; 1999 May; 28(5):447-51. PubMed ID: 10376368
[TBL] [Abstract][Full Text] [Related]
16. Dermatologic manifestation of hyperandrogenism: a retrospective chart review.
Clark CM; Rudolph J; Gerber DA; Glick S; Shalita AR; Lowenstein EJ
Skinmed; 2014; 12(2):84-8. PubMed ID: 24933845
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.
Housman E; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):847.e1-847.e10; quiz 857-8. PubMed ID: 25437977
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients.
Hong JS; Kwon HH; Park SY; Jung JY; Yoon JY; Min S; Choi YM; Suh DH
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):42-7. PubMed ID: 24628922
[TBL] [Abstract][Full Text] [Related]
19. Dermatologic manifestations of polycystic ovary syndrome.
Lee AT; Zane LT
Am J Clin Dermatol; 2007; 8(4):201-19. PubMed ID: 17645376
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A
Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
